Advertisement
Screener

ALSERES PHARMACEUTICALS INC /DE Capital Expenditures

ALSERES PHARMACEUTICALS INC /DE Capital Expenditures

ALSERES PHARMACEUTICALS INC /DE reported Capital Expenditures of $1.65 million for the 254-month period ending 2013-12-31, per its 10-K filed 2014-04-10.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2014-04-10

  • ALSERES PHARMACEUTICALS INC /DE payments to acquire property, plant, and equipment for the quarter ending 2011-12-31 was $0.00.
  • ALSERES PHARMACEUTICALS INC /DE payments to acquire property, plant, and equipment for fiscal 2011 was $2.37K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 224 monthPayments to Acquire Property, Plant, and Equipment 227 monthPayments to Acquire Property, Plant, and Equipment 230 monthPayments to Acquire Property, Plant, and Equipment 233 monthPayments to Acquire Property, Plant, and Equipment 236 monthPayments to Acquire Property, Plant, and Equipment 239 monthPayments to Acquire Property, Plant, and Equipment 242 monthPayments to Acquire Property, Plant, and Equipment 245 monthPayments to Acquire Property, Plant, and Equipment 248 monthPayments to Acquire Property, Plant, and Equipment 251 monthPayments to Acquire Property, Plant, and Equipment 254 month
2013-12-31$1.65M
10-K · filed 2014-04-10
2013-09-30$1.65M
10-Q · filed 2013-11-14
2013-06-30$1.65M
10-Q · filed 2013-08-09
2013-03-31$1.65M
10-Q · filed 2013-05-17
2012-12-31$1.65M
10-K · filed 2013-04-01
2012-09-30$1.65M
10-Q · filed 2012-11-14
2012-06-30$1.65M
10-Q · filed 2012-08-13
2012-03-31$1.65M
10-Q · filed 2012-05-11
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01
$2.37K
10-K · filed 2013-04-01
$1.65M
10-K · filed 2012-03-29
2011-09-30$2.37K
10-Q · filed 2012-11-14
$1.65M
10-Q · filed 2011-11-10
2011-06-30$1.65M
10-Q · filed 2011-08-11